Prices of paediatric vaccines in European vaccination programmes
Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe. Methods: The on-line survey targeted to NVP managers collected data referred to the information available on 31 December 2016. T...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013622300133X |
_version_ | 1827582029859913728 |
---|---|
author | Heini Salo Milda Sakalauskaitè Daniel Lévy-Bruhl Ann Lindstrand Palle Valentiner-Branth Ole Wichmann Taneli Puumalainen |
author_facet | Heini Salo Milda Sakalauskaitè Daniel Lévy-Bruhl Ann Lindstrand Palle Valentiner-Branth Ole Wichmann Taneli Puumalainen |
author_sort | Heini Salo |
collection | DOAJ |
description | Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe. Methods: The on-line survey targeted to NVP managers collected data referred to the information available on 31 December 2016. The prices of vaccines were categorised into three groups. The price per child 1) fully vaccinated comprised all vaccines and doses offered in the NVP; 2) vaccinated with standard vaccines comprised the vaccines included in the NVP in all countries; 3) vaccinated with recent vaccines comprised the pneumococcal conjugate, human papillomavirus and rotavirus vaccines. Results: In the 23 out of 32 countries that answered the survey, 17 funded the vaccines by taxes and six by social insurance. 18 countries procured the vaccines through public tenders or negotiations. Five countries purchased the vaccines by healthcare providers and reimbursed from the health insurance system.In the countries with vaccine procurement through public tenders the price per child vaccinated with standard vaccines ranged from €59 to €117 when using pentavalent and from €98 to €220 when using hexavalent vaccines. The mean price per child vaccinated with recent vaccines was €130 for the countries that offered pneumococcal conjugate and human papillomavirus vaccines and €142 for the countries that in addition included rotavirus vaccine.In the countries that purchased the vaccines by healthcare providers and reimbursed from the health insurance system the price per child vaccinated with standard vaccines ranged from €136 to €427. Conclusions: The vaccine prices differ notably in Europe. Prices were lower in countries where vaccines in the NVP were tax-funded and nationally or regionally procured. Improved procurement systems could lead to substantial savings or possibilities to introduce more vaccines into the NVP. |
first_indexed | 2024-03-08T22:44:43Z |
format | Article |
id | doaj.art-d772fa7100fb4bbdb45779d646223788 |
institution | Directory Open Access Journal |
issn | 2590-1362 |
language | English |
last_indexed | 2024-03-08T22:44:43Z |
publishDate | 2023-12-01 |
publisher | Elsevier |
record_format | Article |
series | Vaccine: X |
spelling | doaj.art-d772fa7100fb4bbdb45779d6462237882023-12-17T06:41:34ZengElsevierVaccine: X2590-13622023-12-0115100392Prices of paediatric vaccines in European vaccination programmesHeini Salo0Milda Sakalauskaitè1Daniel Lévy-Bruhl2Ann Lindstrand3Palle Valentiner-Branth4Ole Wichmann5Taneli Puumalainen6Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland; Corresponding author.Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, FinlandSanté Publique France, Agence Nationale de Santé Publique, Saint-Maurice cedex, FrancePublic Health Agency of Sweden, Stockholm, SwedenDepartment of Infectious Disease Epidemiology and Prevention, Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, DenmarkRobert Koch Institute, Berlin, GermanyInfectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland; Department for Safety, Security and Health, Ministry of Social Affairs and Health, Helsinki, FinlandObjective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe. Methods: The on-line survey targeted to NVP managers collected data referred to the information available on 31 December 2016. The prices of vaccines were categorised into three groups. The price per child 1) fully vaccinated comprised all vaccines and doses offered in the NVP; 2) vaccinated with standard vaccines comprised the vaccines included in the NVP in all countries; 3) vaccinated with recent vaccines comprised the pneumococcal conjugate, human papillomavirus and rotavirus vaccines. Results: In the 23 out of 32 countries that answered the survey, 17 funded the vaccines by taxes and six by social insurance. 18 countries procured the vaccines through public tenders or negotiations. Five countries purchased the vaccines by healthcare providers and reimbursed from the health insurance system.In the countries with vaccine procurement through public tenders the price per child vaccinated with standard vaccines ranged from €59 to €117 when using pentavalent and from €98 to €220 when using hexavalent vaccines. The mean price per child vaccinated with recent vaccines was €130 for the countries that offered pneumococcal conjugate and human papillomavirus vaccines and €142 for the countries that in addition included rotavirus vaccine.In the countries that purchased the vaccines by healthcare providers and reimbursed from the health insurance system the price per child vaccinated with standard vaccines ranged from €136 to €427. Conclusions: The vaccine prices differ notably in Europe. Prices were lower in countries where vaccines in the NVP were tax-funded and nationally or regionally procured. Improved procurement systems could lead to substantial savings or possibilities to introduce more vaccines into the NVP.http://www.sciencedirect.com/science/article/pii/S259013622300133XVaccinePriceProcurementFundingChildhood vaccinesNational vaccination programme |
spellingShingle | Heini Salo Milda Sakalauskaitè Daniel Lévy-Bruhl Ann Lindstrand Palle Valentiner-Branth Ole Wichmann Taneli Puumalainen Prices of paediatric vaccines in European vaccination programmes Vaccine: X Vaccine Price Procurement Funding Childhood vaccines National vaccination programme |
title | Prices of paediatric vaccines in European vaccination programmes |
title_full | Prices of paediatric vaccines in European vaccination programmes |
title_fullStr | Prices of paediatric vaccines in European vaccination programmes |
title_full_unstemmed | Prices of paediatric vaccines in European vaccination programmes |
title_short | Prices of paediatric vaccines in European vaccination programmes |
title_sort | prices of paediatric vaccines in european vaccination programmes |
topic | Vaccine Price Procurement Funding Childhood vaccines National vaccination programme |
url | http://www.sciencedirect.com/science/article/pii/S259013622300133X |
work_keys_str_mv | AT heinisalo pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT mildasakalauskaite pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT daniellevybruhl pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT annlindstrand pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT pallevalentinerbranth pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT olewichmann pricesofpaediatricvaccinesineuropeanvaccinationprogrammes AT tanelipuumalainen pricesofpaediatricvaccinesineuropeanvaccinationprogrammes |